Product Overview

AOP Orphan's focus is on Rare Diseases. The portfolio comprises products in the following therapeutic areas: HematoOncology, Cardiology & Pulmonology, Neurology and Metabolic Disorders. AOP Orphan’s strategic goal is to constantly deliver new treatment options with respect to Rare Diseases.

HematoOncology

Anagrelide AOP

Drug Facts
Active Ingredient
Anagrelide
HematoOncology

BESREMi®

BESREMi® is indicated as monotherapy in adults for the treatment of Polycythaemia Vera without symptomatic splenomegaly.

Drug Facts
Active Ingredient
Ropeginterferon alfa-2b
Cardiology & Pulmonology

Empressin®

Drug Facts
Active Ingredient
Agripressin
Neurology & Metabolic Disorders

Feraccru®

Drug Facts
Active Ingredient
Ferric-maltol
Neurology & Metabolic Disorders

Naltrexone AOP

Drug Facts
Active Ingredient
Neurology & Metabolic Disorders

Ocaliva®

Drug Facts
Active Ingredient
Obeticholic acid
Cardiology & Pulmonology

Rapibloc®

Drug Facts
Active Ingredient
Neurology & Metabolic Disorders

Tetmodis®

Drug Facts
Active Ingredient
Tetrabenazine
Neurology & Metabolic Disorders

Wakix®

Drug Facts
Active Ingredient
Pitolisant